| Wk 1: Chapter One: Pharamacology: An Introduction |
| -KeyTerms |
| -Drug sources, terminology and basic concepts |
| -Drug safety, nomenclature, drug laws and legal aspects |
| Chapter Two: Pharmacokinetics and Factors of Individual Variation |
| -Drug forms and routes of administration |
| -Pharmacokinetic Process |
| -Clinical factors of intenstity and individual variation |
| -Pediatric considerations |
| -Drug interactions, drug use and drug abuse |
| Wk 2: Chapter Three: Geriatric Pharmacology |
| -Drug use, absorbtion and distribution in the elderly |
| -Drug metabolism and excretion |
| -Effects of age on drug response and drug compliance |
| Chapter Four: Math Review and Dosage Calculations |
| -Fractions, decimals and percents |
| -Dosage calculations |
| -Calculating Dosages and pediatric dosages |
| Wk 3: Chapter Ten: Local Anesthetics |
| -Mechanism of action, types, and routes of administration |
| -Cardiovascular effects and adverse effects |
| -Clinical applications and special considerations |
| Chapter Twenty One: Review of Cardiac Physiology and Pathology |
| -Cardiac muscle, conduction, EKG, and nerve supply |
| -Main diseases of the heart |
| Chapter Twenty Two: Treatment of Heart Failure |
| -Chronic heart failure, diuretic therapy, vasodilator therapy |
| -Adrenergic Beta-Blockers in CHF |
| -Cardiac glycosides |
| Wk 4: Chapter Twenty Three: Antiarrhythmic Drugs |
| -Types of Arrhythmias |
| -Classes 1-4 Antiarrhythmic drugs |
| -Special considerations and preferred therapy |
| Chapter Twenty Four: Antianginal Drugs |
| -Classification of angina pectoris |
| -Nitrates |
| -Beta-adrenergic blocking drugs |
| -Calcium channel blockers |
| -Preferred therapy for treatment of angina |
| Wk 5: Chapter Twenty Five: Diuretics |
| -Clinical indication for diuretic use |
| -Renal physiology and conditions associate with renal dysfunction |
| -Osmotic diuretics |
| -Carbonic anhydrase inhibitors |
| -Thiazide, Thiazide-like, and organic acid (loop) diuretics |
| -Potassium-sparing diuretics |
| -ADH antagonists and miscellaneous diuretics |
| -Preferred treatment, adverse effects, and drug interactions |
| Wk 6: Chapter Twenty Six: Antihypertensive Drugs |
| -Physiologic factors that determine blood pressure |
| -Factors affecting blood pressure |
| -Diuretics |
| -Drugs that reduce sympathetic activity |
| -Vasodilator drugs |
| -Drugs that reduce the activity of Angiotensin II |
| -Treatment of hypertensive crisis |
| -Patient education and monitoring, preferred treatment |
| Chapter Twenty Seven: Anticoagulants and Coagulants |
| -Blood clot formation |
| -Anticoagulant mechanism of action |
| -Charasteristics of the Heparins |
| -Oral anticoagulants and antiplatelet drugs |
| -Special considerations, contraindications, and drug interactions |
| -Fibrinolytic/thrombolytic drugs |
| -Clinical uses of coagulants/hemostatics |
| Wk 7: Chapter Thirty Two: Hypolipidemic Drugs |
| -Atherosclerosis and arterial disease |
| -Lipids, lipoproteins, and cholesterol |
| -Classes of hypolipidemic drugs |
| -HMG-CoA Reductase Inhibitors: Statins |
| -Cholesterol absorption inhibitors |
| -Bile acid sequestrants and other hypolipidemic drugs |
| -Contraindications and drug interactions |
| Final Exam |